History

COOPER SA is one of the oldest pharmaceutical manufacturers in Greece.

It was founded by Constantine Lemos, a pharmacist who opened a pharmacy in Omonia on Panepistimiou Street (where the National Bank is today).

In 1936, he founded COOPER SA, registered in Athens, in collaboration with Dr. Albert Salmon, founder of the French company, LA COOPERATION PHARMACEUTIQUE FRANCAISE, on the same premises (64 Aristovoulou, 11853 Petralona) it still occupies today, with an initial surface area 1.900m2.

During World War II, the company was the main supplier of the Red Cross, though it suffered extensive damage from both German bombardments and in the course of the civil war.

The damage was gradually repaired and partial operation began in 1945. Full operation was restored by 1946.

The next step taken by the company was to negotiate partnership agreements for the production and distribution of products to pharmacies, wholesalers and hospitals throughout Greece with the following companies:

SPECIA RHONE-POULENC - France (1947)
LABORATOIRES HOUDE - France (1947)
DON BAXTER INC. - USA (1958)
LABORATOIRES LOGEAIS - France (1960)
TIE WARRENTEED PRODUCT CO. - USA (1963)
MAY & BAKER Lill. - UK (1964)
LABORATOIRES BOTTU - France (1967)
ELI LILL Y & CO - USA (1970)

In 1948 facilities were expanded by 1000 m2 for manufacture of SPECIA HELLAS LTD products and a new 750 m2 extension was devoted to the manufacture of BAXTER products (serum injections).

In 1961 COOPER SA acquired a majority shareholding in SPECIA HELLAS LTD which was established in the meantime between COOPER SA and SPECIA/RHONE POULENC for the production of sterile products, primarily antibiotics.

The collaboration between the two companies led to the creation of the joint-venture company Rhone Poulenc - Cooper which, through a series of acquisitions and mergers of the parent company Rhone Poulenc in 1998, led to the termination of the cooperative agreement between the two companies and its new independent shareholder relationship.

In 2001 COOPER SA entered a new partnership with Fresenius Kabi Hellas SA (a subsidiary of Fresenius A.G. Germany) for contract manufacturing of large volume injectable solutions on behalf of FKH for the Greek market, as well as their distribution throughout the country.

In June 2006, COOPER SA launched its new, dynamic course of development in the healthcare field. Reorganization, integration of new management and marketing methods, as well as the dedication of the staff to achieving quality objectives in the production process, as well effective promotion and distribution of its products have laid the foundations for its future progress. 2009 marked the expansion of the cooperation agreementwith Fresenius Kabi Hellas in the hospital sector to include distribution, promotion and sale of a range of generic injectable products (antibiotics and anesthetics).